Research graph

References

References from Supplementary Table S3 from A Phase II Study of Berzosertib in Combination with Carboplatin Compared with Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer. Local targets link to admitted publications; unresolved targets remain external evidence.